|7.29||-0.14 / -1.88%|
Data as of 4:00pm ET
|7.29||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a +9.74% increase from the last price of 7.29.
The current consensus among 2 polled investment analysts is to Hold stock in PDL BioPharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.